Home » Prices » BMV:RYTM

Rhythm Pharmaceuticals Inc. BMV:RYTM

Today's live share price, quote history, chart & news

Price:
0.00 MXN
Change:
+ (0%)
Key Stats
Price open
Previous close
Market cap 0
Volume 0
Day high
Day low
Year high 0
Year low 0
Year to date change N.A
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals, Inc. engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. It focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity. Its product candidate includes setmelanotide, an MC4R agonist designed to restore impaired MC4R pathway function caused by genetic variants that occur upstream of the MC4R. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Company information

Company name
Rhythm Pharmaceuticals, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
CEO
David P. Meeker
Address
222 Berkeley Street, Boston, MA, 02116
Country
United States
Contact information
1.857.264.4280
Website
http://www.rhythmtx.com
Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.